Most chronic pain conditions have been traditionally treated with escalating doses of opiates and benzodiazepines. Unfortunately for many, these medications eventually cease to relieve the pain to the level they once did. Stopping them may not be an option as symptoms of withdrawal can be too much to bear. Physical dependency can turn to addiction, resulting in a loss of control, quality, and happiness in your life.
Fortunately, Ketamine and NAD+ infusions may significantly help those who suffer from chronic pain to find relief. Ketamine has been used for decades as a treatment for many acute and chronic pain syndromes including post surgical pain, CRPS I & CRPS II, phantom limb pain, and cancer pain. More recently, Ketamine has been shown to help with other chronic pain syndromes such as fibromyalgia, migraine headaches, and neuropathic pain.
Typically treatment for chronic pain syndromes requires longer infusions at a higher dosage of Ketamine. Infusions can last anywhere from 1-4 hours depending on individual treatment plans. After an initial series of treatments grouped closely together, patients will know if Ketamine works for their pain. If treatments are successful, most patients will return for single “booster” infusions monthly or quarterly. Additionally, Ketamine lozenges for home use may offer sustained benefit.
Please see our Ketamine Therapy section of this website for what to expect during an actual treatment.
Those who suffer from chronic pain are typically deficient in NAD+. Intravenous infusions can help restore levels of this co-enzyme that drives so many important reactions in a healthy body. NAD+ has shown promise in helping to reduce inflammation, and improve neuron cell vitality. Supplementing the body’s need for NAD+ will help with energy levels, improve sleep patterns, and protect against future neuronal injury.
Additionally, for those who wish to stop taking opiates and benzodiazepines completely, NAD+ and Ketamine infusions over a week to ten days may allow for a “painless detox” experience.